Answers are grounded in this paper and cite their sources.
Background Hip dysfunction resulting from stroke or aging causes significant gait impairments. While robotic hip exoskeletons are emerging as assistive technologies, a gap remains between engineering design and clinical application. This systematic review addresses this gap by synthesizing the technical features of current devices and their validation in clinical settings. Methods A systematic search was conducted following PRISMA-2020 guidelines in PubMed, Web of Science, IEEE Xplore, Scopus, and ScienceDirect, for studies published from 2015 to 2025. We included nineteen peer-reviewed human subject studies evaluating hip-specific exoskeletons for gait rehabilitation. A risk of bias assessment was conducted in all included papers. Results Across included studies, hip exoskeleton use was associated with reported improvements in key gait parameters. Notably, outcomes included increased walking speed, step length, and improved symmetry across populations. Several individual studies reported reductions in metabolic cost and improvements in functional mobility that approached or exceeded established clinical thresholds. Bilateral assistance and adaptive control strategies were frequently used in studies reporting favorable outcomes, although causal relationships cannot be inferred. Conclusion Robotic hip exoskeletons demonstrate promising short-term functional benefits in controlled settings, though evidence supporting sustained clinical impact remains limited. However, barriers including a lack of standardized metrics, high costs, and limited transferability to real-world environments remain. Future work must focus on larger clinical trials and usability to establish these devices in routine neurorehabilitation. Trial registration PROSPERO CRD420261300780.
No takes yet. Share an insight, caveat, or question.
Nigmetolla et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: